Skip to main content
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology 5/2011

01.05.2011 | Pediatrics

Characterization of Bangerter filter effect in mild and moderate anisometropic amblyopia: predictive factors for the visual outcome

verfasst von: Carlos Laria, David P. Piñero, Jorge L. Alió

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 5/2011

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To evaluate the outcome achieved by using Bangerter filters in cases of mild and moderate anisometropic amblyopia, and to define the predictive factors for the final visual outcome.

Methods

Prospective study comprising 62 children (age range 3–11 years) with unilateral amblyopia associated with myopic or hyperopic anisometropia. In all cases, the use of Bangerter filters were prescribed for amblyopia treatment due to the unsuccessful outcome with refractive correction. The prescribed filter always induced a visual acuity reduction in the non-amblyopic eye of 2 lines below the BSCVA of the amblyopic eye. A follow-up of 12 months was completed.

Results

A statistically significant improvement in visual acuity was observed at 3 months in both groups, amblyopic and non-amblyopic eyes (p < 0.01). At 6, 9 and 12 months, additional small but statistically significant improvements in visual acuity were detected only in the amblyopic group (p ≤ 0.02). Filter density had to be changed during the follow-up in a total of 22 eyes (35.5%). A significant correlation of the visual acuity with the baseline interocular visual acuity difference was found at 3 months (r = 0.44, p < 0.01), but not at the end of the follow-up (r = 0.12, p = 0.36). Multiple linear regression analysis revealed that the final visual outcome was significantly correlated with the baseline visual acuity, sphere and the difference in visual acuity between eyes (R2: 0.42, p < 0.01).

Conclusions

Bangerter filters are useful for treating mild or moderate amblyopia due to anisometropia, but ocular dominance inversion should be maintained during treatment for obtaining an optimized outcome.
Literatur
1.
2.
Zurück zum Zitat Ciuffreda KJ, Levi D, Selenow A (1991) Amblyopia: basic and clinical aspects. Chapter 1: history, definitions, classifications and prevalence. Butterworth-Heinemann, Boston, pp 1-42 Ciuffreda KJ, Levi D, Selenow A (1991) Amblyopia: basic and clinical aspects. Chapter 1: history, definitions, classifications and prevalence. Butterworth-Heinemann, Boston, pp 1-42
3.
Zurück zum Zitat Pediatric Eye Disease Investigator Group (2006) Treatment of anisometropic amblyopia in children with refractive correction. Ophthalmology 113:895–903CrossRef Pediatric Eye Disease Investigator Group (2006) Treatment of anisometropic amblyopia in children with refractive correction. Ophthalmology 113:895–903CrossRef
4.
Zurück zum Zitat Pediatric Eye Disease Investigator Group (2005) Randomized trial of treatment of amblyopia in children aged 7 to 17 years. Arch Ophthalmol 123:437–447CrossRef Pediatric Eye Disease Investigator Group (2005) Randomized trial of treatment of amblyopia in children aged 7 to 17 years. Arch Ophthalmol 123:437–447CrossRef
5.
Zurück zum Zitat Stewart CE, Moseley MJ, Fielder AR, Stephens DA, Cooperative MOTAS (2004) Refractive adaptation in amblyopia: quantification of effect and implications for practice. Br J Ophthalmol 88:1552–1556PubMedCrossRef Stewart CE, Moseley MJ, Fielder AR, Stephens DA, Cooperative MOTAS (2004) Refractive adaptation in amblyopia: quantification of effect and implications for practice. Br J Ophthalmol 88:1552–1556PubMedCrossRef
6.
Zurück zum Zitat Alió J, Laria C (2007) Diagnosis and treatment of amblyopia. In: Garg A, Prost ME, Azad R (eds) Surgical and medical management of pediatric ophthalmology. Jaypee Brothers Medical Publishers Ltd, New Delhi, pp 855-874 Alió J, Laria C (2007) Diagnosis and treatment of amblyopia. In: Garg A, Prost ME, Azad R (eds) Surgical and medical management of pediatric ophthalmology. Jaypee Brothers Medical Publishers Ltd, New Delhi, pp 855-874
7.
Zurück zum Zitat Menon V, Shailesh G, Sharma P, Saxena R (2008) Clinical trial of patching versus atropine penalization for the treatment of anisometropic amblyopia in older children. J AAPOS 12:493–497PubMedCrossRef Menon V, Shailesh G, Sharma P, Saxena R (2008) Clinical trial of patching versus atropine penalization for the treatment of anisometropic amblyopia in older children. J AAPOS 12:493–497PubMedCrossRef
8.
Zurück zum Zitat Pediatric Eye Disease Investigator Group (2006) A randomized trial to evaluate 2 hours of daily patching for strabismic and anisometropic amblyopia in children. Ophthalmology 113:904–912CrossRef Pediatric Eye Disease Investigator Group (2006) A randomized trial to evaluate 2 hours of daily patching for strabismic and anisometropic amblyopia in children. Ophthalmology 113:904–912CrossRef
9.
Zurück zum Zitat Pediatric Eye Disease Investigator Group (2005) A randomized pilot study of near activities versus non-near activities during patching therapy for amblyopia. J AAPOS 9:129–136CrossRef Pediatric Eye Disease Investigator Group (2005) A randomized pilot study of near activities versus non-near activities during patching therapy for amblyopia. J AAPOS 9:129–136CrossRef
10.
Zurück zum Zitat Pediatric Eye Disease Investigator Group (2003) A comparison of atropine and patching treatments for moderate amblyopia by patient age, cause of amblyopia, depth of amblyopia, and other factors. Ophthalmology 110:1632–1638CrossRef Pediatric Eye Disease Investigator Group (2003) A comparison of atropine and patching treatments for moderate amblyopia by patient age, cause of amblyopia, depth of amblyopia, and other factors. Ophthalmology 110:1632–1638CrossRef
11.
Zurück zum Zitat Pediatric Eye Disease Investigator Group (2002) A randomized trial of atropine vs. patching for treatment of moderate amblyopia in children. Arch Ophthalmol 120:268–278 Pediatric Eye Disease Investigator Group (2002) A randomized trial of atropine vs. patching for treatment of moderate amblyopia in children. Arch Ophthalmol 120:268–278
12.
Zurück zum Zitat Keech RV, Ottar W, Zhang L (2002) The minimum occlusion trial for the treatment of amblyopia. Ophthalmology 109:2261–2264PubMedCrossRef Keech RV, Ottar W, Zhang L (2002) The minimum occlusion trial for the treatment of amblyopia. Ophthalmology 109:2261–2264PubMedCrossRef
13.
Zurück zum Zitat Moseley MJ, Fielder AR, Irwin M, Jones HS, Auld RJ (1997) Effectiveness of occlusion therapy in ametropic amblyopia: a pilot study. Br J Ophthalmol 81:956–961PubMedCrossRef Moseley MJ, Fielder AR, Irwin M, Jones HS, Auld RJ (1997) Effectiveness of occlusion therapy in ametropic amblyopia: a pilot study. Br J Ophthalmol 81:956–961PubMedCrossRef
14.
Zurück zum Zitat Foley-Nolan A, McCann A, O’Keefe M (1997) Atropine penalization vs. occlusion as the primary treatment for amblyopia. Br J Ophthalmol 81:54–57PubMedCrossRef Foley-Nolan A, McCann A, O’Keefe M (1997) Atropine penalization vs. occlusion as the primary treatment for amblyopia. Br J Ophthalmol 81:54–57PubMedCrossRef
15.
Zurück zum Zitat Repka MX, Kraker RT, Beck RW, Birch E, Cotter SA, Holmes JM, Hertle RW, Hoover DL, Klimek DL, Marsh-Tootle W, Scheiman MM, Suh DW, Weakley DR, Pediatric Eye Disease Investigator Group (2009) Treatment of severe amblyopia with weekend atropine: Results from 2 randomized clinical trials. J AAPOS 13:258–263PubMedCrossRef Repka MX, Kraker RT, Beck RW, Birch E, Cotter SA, Holmes JM, Hertle RW, Hoover DL, Klimek DL, Marsh-Tootle W, Scheiman MM, Suh DW, Weakley DR, Pediatric Eye Disease Investigator Group (2009) Treatment of severe amblyopia with weekend atropine: Results from 2 randomized clinical trials. J AAPOS 13:258–263PubMedCrossRef
16.
Zurück zum Zitat Kaye SB, Kaye LC, Noonan C, Tripathi A, Ashwin P, Cota N, Clark D, Butcher J (2002) Combined optical and atropine penalization for the treatment of strabismic and anisometropic amblyopia. J AAPOS 6:289–293PubMedCrossRef Kaye SB, Kaye LC, Noonan C, Tripathi A, Ashwin P, Cota N, Clark D, Butcher J (2002) Combined optical and atropine penalization for the treatment of strabismic and anisometropic amblyopia. J AAPOS 6:289–293PubMedCrossRef
17.
Zurück zum Zitat Simons K, Stein L, Sener EC, Vitale S, Guyton DL (1997) Full-time atropine, intermittent atropine, optical penalization, binocular outcome in treatment of strabismic amblyopia. Ophthalmology 104:2143–2145PubMed Simons K, Stein L, Sener EC, Vitale S, Guyton DL (1997) Full-time atropine, intermittent atropine, optical penalization, binocular outcome in treatment of strabismic amblyopia. Ophthalmology 104:2143–2145PubMed
18.
Zurück zum Zitat France TD, France LW (1999) Optical penalization can improve vision after occlusion treatment. J AAPOS 3:341–343PubMedCrossRef France TD, France LW (1999) Optical penalization can improve vision after occlusion treatment. J AAPOS 3:341–343PubMedCrossRef
19.
Zurück zum Zitat McIntyre A, Fells P (1996) Bangerter foils: A new approach to the management of pathological intractable diplopia. Br Orthopt J 53:43–47 McIntyre A, Fells P (1996) Bangerter foils: A new approach to the management of pathological intractable diplopia. Br Orthopt J 53:43–47
20.
Zurück zum Zitat Bangerter A (1960) Die Okklusion in der Pleoptik und Orthoptik. Klin Monatsbl Augenheilkd 136:305–331 Bangerter A (1960) Die Okklusion in der Pleoptik und Orthoptik. Klin Monatsbl Augenheilkd 136:305–331
21.
22.
Zurück zum Zitat Pediatric Eye Disease Investigator Group (2003) Impact of patching and atropine treatment on the child and family in the Amblyopia Treatment Study. Arch Ophthalmol 121:1625–1632CrossRef Pediatric Eye Disease Investigator Group (2003) Impact of patching and atropine treatment on the child and family in the Amblyopia Treatment Study. Arch Ophthalmol 121:1625–1632CrossRef
23.
Zurück zum Zitat Fielder AR, Irwin M, Auld R, Cocker KD, Jones HS, Moseley MJ (1995) Compliance in amblyopia therapy: objective monitoring of occlusion. Br J Ophthalmol 79:585–589PubMedCrossRef Fielder AR, Irwin M, Auld R, Cocker KD, Jones HS, Moseley MJ (1995) Compliance in amblyopia therapy: objective monitoring of occlusion. Br J Ophthalmol 79:585–589PubMedCrossRef
24.
Zurück zum Zitat Campos EC, Chiesi C, Rozzi N (1991) Intossicazione da atropina in corso di terapia antiambliopica. G It Ortotte Tec Strum Oft 8:185–188 Campos EC, Chiesi C, Rozzi N (1991) Intossicazione da atropina in corso di terapia antiambliopica. G It Ortotte Tec Strum Oft 8:185–188
25.
Zurück zum Zitat Lowe RF (1965) Atropine treatment for amblyopia ex anopsia. Br Orthopt J 22:35–42 Lowe RF (1965) Atropine treatment for amblyopia ex anopsia. Br Orthopt J 22:35–42
26.
Zurück zum Zitat Abraham SV (1954) Intraepithelial cysts of the iris. Am J Ophthalmol 37:327–331PubMed Abraham SV (1954) Intraepithelial cysts of the iris. Am J Ophthalmol 37:327–331PubMed
27.
Zurück zum Zitat Pediatric Eye Disease Investigator Group Writing Committee, Rutstein RP, Quinn GE, Lazar EL, Beck RW, Bonsall DJ, Cotter SA, Crouch ER, Holmes JM, Hoover DL, Leske DA, Lorenzana IJ, Repka MX, Suh DW (2010) A randomized trial comparing Bangerter filters and patching for the treatment of moderate amblyopia in children. Ophthalmology 117(5):998–1004PubMedCrossRef Pediatric Eye Disease Investigator Group Writing Committee, Rutstein RP, Quinn GE, Lazar EL, Beck RW, Bonsall DJ, Cotter SA, Crouch ER, Holmes JM, Hoover DL, Leske DA, Lorenzana IJ, Repka MX, Suh DW (2010) A randomized trial comparing Bangerter filters and patching for the treatment of moderate amblyopia in children. Ophthalmology 117(5):998–1004PubMedCrossRef
28.
Zurück zum Zitat Agervi P, Kugelberg U, Kugelberg M, Simonsson G, Fornander M, Zetterström C (2009) Treatment of anisometropic amblyopia with spectacles or in combination with translucent Bangerter filters. Ophthalmology 116:1475–1480PubMedCrossRef Agervi P, Kugelberg U, Kugelberg M, Simonsson G, Fornander M, Zetterström C (2009) Treatment of anisometropic amblyopia with spectacles or in combination with translucent Bangerter filters. Ophthalmology 116:1475–1480PubMedCrossRef
29.
Zurück zum Zitat Holladay JT (1997) Proper method for calculating average visual acuity. J Refract Surg 13:388–391PubMed Holladay JT (1997) Proper method for calculating average visual acuity. J Refract Surg 13:388–391PubMed
30.
Zurück zum Zitat North RV, Kelly ME (1991) Atropine occlusion in the treatment of strabismic amblyopia and its effect on the non-amblyopic eye. Ophthalmic Physiol Opt 11:113–117PubMedCrossRef North RV, Kelly ME (1991) Atropine occlusion in the treatment of strabismic amblyopia and its effect on the non-amblyopic eye. Ophthalmic Physiol Opt 11:113–117PubMedCrossRef
31.
Zurück zum Zitat Agervi P, Kugelberg U, Kugelberg M, Simonsson G, Fornander M, Zetterström C (2010) Randomized evaluation of spectacles plus alternate-day occlusion to treat amblyopia. Ophthalmology 117:381–387PubMedCrossRef Agervi P, Kugelberg U, Kugelberg M, Simonsson G, Fornander M, Zetterström C (2010) Randomized evaluation of spectacles plus alternate-day occlusion to treat amblyopia. Ophthalmology 117:381–387PubMedCrossRef
32.
Zurück zum Zitat Dorey SE, Adams GG, Lee JP, Sloper JJ (2001) Intensive occlusion therapy for amblyopia. Br J Ophthalmol 85:310–313PubMedCrossRef Dorey SE, Adams GG, Lee JP, Sloper JJ (2001) Intensive occlusion therapy for amblyopia. Br J Ophthalmol 85:310–313PubMedCrossRef
33.
Zurück zum Zitat Moseley MJ, Fielder AR, Irwin M, Jones HS, Auld RJ (1997) Effectiveness of occlusion therapy in ametropic amblyopia: a pilot study. Br J Ophthalmol 81:956–961PubMedCrossRef Moseley MJ, Fielder AR, Irwin M, Jones HS, Auld RJ (1997) Effectiveness of occlusion therapy in ametropic amblyopia: a pilot study. Br J Ophthalmol 81:956–961PubMedCrossRef
34.
Zurück zum Zitat Odell NV, Leske DA, Hatt SR, Adams WE, Holmes JM (2008) The effect of Bangerter filters on optotype acuity, Vernier acuity, and contrast sensitivity. J AAPOS 12:555–559PubMedCrossRef Odell NV, Leske DA, Hatt SR, Adams WE, Holmes JM (2008) The effect of Bangerter filters on optotype acuity, Vernier acuity, and contrast sensitivity. J AAPOS 12:555–559PubMedCrossRef
35.
Zurück zum Zitat Arikan G, Yaman A, Berk AT (2005) Efficacy of occlusion treatment in amblyopia and clinical risk factors affecting the results of treatment. Strabismus 13:63–69PubMedCrossRef Arikan G, Yaman A, Berk AT (2005) Efficacy of occlusion treatment in amblyopia and clinical risk factors affecting the results of treatment. Strabismus 13:63–69PubMedCrossRef
36.
Zurück zum Zitat Hussein MA, Coats DK, Muthialu A, Cohen E, Paysse EA (2004) Risk factors for treatment failure of anisometropic amblyopia. J AAPOS 8:429–434PubMedCrossRef Hussein MA, Coats DK, Muthialu A, Cohen E, Paysse EA (2004) Risk factors for treatment failure of anisometropic amblyopia. J AAPOS 8:429–434PubMedCrossRef
37.
Zurück zum Zitat Mazow ML, Chuang A, Vital MC, Prager T (2000) 1999 Costenbander Lecture. Outcome study in amblyopia: treatment and practice pattern variations. J AAPOS 4:1–9PubMedCrossRef Mazow ML, Chuang A, Vital MC, Prager T (2000) 1999 Costenbander Lecture. Outcome study in amblyopia: treatment and practice pattern variations. J AAPOS 4:1–9PubMedCrossRef
Metadaten
Titel
Characterization of Bangerter filter effect in mild and moderate anisometropic amblyopia: predictive factors for the visual outcome
verfasst von
Carlos Laria
David P. Piñero
Jorge L. Alió
Publikationsdatum
01.05.2011
Verlag
Springer-Verlag
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 5/2011
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-010-1564-x

Weitere Artikel der Ausgabe 5/2011

Graefe's Archive for Clinical and Experimental Ophthalmology 5/2011 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Metastasen Leitthema

Orbitale und periokuläre metastatische Tumoren galten früher als sehr selten. Aber mit der ständigen Aktualisierung von Medikamenten und Nachweismethoden für die Krebsbehandlung werden neue Chemotherapien und Strahlenbehandlungen eingesetzt. Die …

Staging und Systemtherapie bei okulären und periokulären Metastasen

Metastasen Leitthema

Metastasen bösartiger Erkrankungen sind die häufigsten Tumoren, die im Auge diagnostiziert werden. Sie treten bei ungefähr 5–10 % der Patienten mit soliden Tumoren im Verlauf der Erkrankung auf. Besonders häufig sind diese beim Mammakarzinom und …

CME: Wundheilung nach Trabekulektomie

Trabekulektomie CME-Artikel

Wird ein Glaukom chirurgisch behandelt, ist die anschließende Wundheilung von entscheidender Bedeutung. In diesem CME-Kurs lernen Sie, welche Pathomechanismen der Vernarbung zugrunde liegen, wie perioperativ therapiert und Operationsversagen frühzeitig erkannt werden kann.

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Metastasen Leitthema

Peri- sowie intraokuläre Metastasen sind insgesamt gesehen selten und meist Zeichen einer fortgeschrittenen primären Tumorerkrankung. Die Therapie ist daher zumeist palliativ und selten kurativ. Zudem ist die Therapiefindung sehr individuell. Die …

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.